Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomic Redeems Series A Redeemable Preferred Stock for $50.1M

NEW YORK (GenomeWeb) – NeoGenomics announced after the close of the market on Monday that it has redeemed 6,864,000 million shares of Series A Redeemable Preferred Stock held by an affiliate of General Electric Company for approximately $50.1 million.

In December 2015, NeoGenomics issued more than 14.6 million shares of its Series A Preferred Stock in conjunction with its purchase of Clarient from GE Healthcare. The preferred stock had a face value of $7.50 per share for a total liquidation value of $110 million. The redemption provisions included a discount for redemptions completed in the first four years following the date of issuance, NeoGenomics said. In late 2016, NeoGenomics redeemed 8.1 million shares of the Series A Preferred Stock for $55 million in cash.

The company has now redeemed 100 percent of the Series A Preferred Stock outstanding.

As part of the transaction announced on Monday, the shares were redeemed at $7.30 per share, reflecting $7.16 per share, which is the applicable 4.5 percent redemption discount to the original liquidation preference, plus an additional $0.14 per share in respect of accrued and unpaid dividends for 2018.

NeoGenomics also closed on a $30 million extension to its senior secured credit facility. The company used the proceeds from this facility, along with $20.5 million of cash and borrowing from its revolving credit facility, to redeem the Series A Preferred Stock and to pay certain fees and expenses, it said.

"In less than 30 months sine completing the Clarient acquisition, we have redeemed 100 percent of the $110 million preferred stock issued in conjunction with the deal, at a total redemption cost of just $105 million, using our borrowing capacity and internally generated cash flow," Douglas VanOort, company chairman and CEO said in a statement.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.